-
Article | 2024.02.27
Improving the Detection of Primary Immune Deficiency Diseases for Better Treatment
Primary Immune Deficiency diseases (PIDs) constitute a heterogeneous group of over 300 diseases in which a genetic defect of the immune system leads to an increased susceptibility to infections, sometimes jeopardizing the vital prognosis. The lack of awareness among the medical community about these diseases results in them remaining significantly underdiagnosed, both in children and in milder...
-
Document de presse | 2023.11.20
Study sheds light on evolution of brain folding in cerebellum of mammals
Researchers from the Institut Pasteur have compared the structure of the cerebellum and cerebrum in the brains of 56 mammals, providing insights into the evolution and mechanisms of brain folding.Scientists from the Institut Pasteur have characterised the folding of the cerebellar cortex using data from a sample of 56 mammalian species, allowing them to study the diversity and evolution of...
-
Portrait | 2024.03.05
Carla Saleh, leading the fight against viruses and inequality
When Carla Saleh arrived in France from Argentina aged 25 as a young scientist, she didn't speak a word of French. She now leads her own research unit at the Institut Pasteur.Her goal is to make mosquitoes intolerant to viruses. She is passionate about science, determined to tackle all forms of inequality and discrimination, and always keen to encourage anyone – especially girls and women – with...
-
Report | 2024.03.12
COVID-19: which monoclonal antibodies should be used for vulnerable individuals?
Vaccination does not offer sufficient protection against severe forms of COVID-19 for people with a weakened immune system. For these individuals, monoclonal antibodies have long been the preferred therapeutic solution. But depending on the SARS-CoV-2 variant, the effectiveness of these treatments has fluctuated. Scientists have had to develop novel antibodies that are more effective while also...
-
Article | 2024.03.12
DIAGNOSTIC
DiagnosticFrançois Rieunier, Head of Diagnostic Innovation DevelopmentFrançois Rieunier joined the Technology Transfer and Industrial Partnership Department in 2023 as Head of Dianostic Innovation Development.After a PhD from the University of Montpellier, in Chemistry applied to Biology, François joined the Biological Development team at Sanofi Diagnostic Pasteur in Marnes la Coquette...
-
Article | 2024.03.12
VACCINE
VaccineDr. Sotiris MissailidisHead of Vaccine Innovation DevelopmentSotiris is managing the vaccine portfolio of the Institute Pasteur and leading the Innovation development of vaccine projects from basic research to clinical development, spin-off activities and industrial partnerships for vaccine-related projects. Sotiris joined the Institute Pasteur in 2024, having previously led for...
-
Article | 2024.03.14
Transaction & Partnership
The Transaction & Partnership Team is focused on the preparation, the drafting and the negotiation of contracts with our partners such as non-disclosure agreements, material transfer agreements, licensing agreements, collaborative research agreements and fee for service agreements.
-
Article | 2024.03.14
Startup
The Startup team coordinates the process of creating startups based on Pasteur's discoveries. The team supports scientists at various stages of this process: raising awareness and providing training in entrepreneurship, identifying business creation potential, providing advice, and finding financial and industrial partners. Thanks to its integration in the innovation ecosystem, the Startup team...
-
News | 2024.03.19
Pasteur Museum: transferring the collections to protect them
As part of the work to restore and renovate the Institut Pasteur's historical building, the Pasteur Museum recently embarked on an unprecedented process to transfer its collections. This involves meticulously preparing the items so that they can be stored in dedicated spaces that are suitable for housing such valuable objects.
-
News | 2024.03.25
Tackling flaviviruses and preparing the European Union for emerging threats
The genus flavivirus includes several human pathogens, such as Zika, dengue, West Nile virus (WNV) and yellow fever virus, which persist as major threats to global public health. Yellow4FLAVI, coordinated by Giovanna Barba-Spaeth, Institut Pasteur, comprises 13 partner institutions and is supported by the European Union with with € 8 million. The aim is to use the 17D yellow fever vaccine as...
